
|Articles|February 1, 2004
Topical stymies HIV
Washington - As the number of new cases of human immunodeficiency virus continues to grow, a topical microbicide might offer hope. Applied intravaginally, the agent has completely blocked intravaginal transmission of Simian Immunodeficiency Virus to female monkeys, according to Andrew Blauvelt, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Eli Lilly Trial Shows Superior Outcomes With Ixekizumab and Tirzepatide in Patients With PsA and Obesity
2
Phase 2a Evaluation of Dual OX40L/TNFα Antibody Begins in HS
3
Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026
4
FDA Feedback Supports BLA Pathway for Sonelokimab in HS
5


















